Helena Krist

Design, Protocol, and Rationale of the Clinical Trial with a Novel Statin-Free Artisterol Gel Suspension in Subjects with Suboptimal Cholesterol Levels

Elevated low-density lipoprotein cholesterol (LDL-C) is a causal, modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD). In individuals at low-to-moderate cardiovascular risk who do not meet criteria for lipid-lowering pharmacotherapy, or who are not willing to use statins or are intolerant, non...